1 / 14

Clinical Trial Infrastructure in Centres

Clinical Trial Infrastructure in Centres. Lillian L. Siu Princess Margaret Hospital. Key elements for success. Building a research team Engaging others in your research Be engaged in the work of others who collaborate with your research Know some basic accounting

fergal
Télécharger la présentation

Clinical Trial Infrastructure in Centres

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Clinical Trial Infrastructure in Centres Lillian L. Siu Princess Margaret Hospital

  2. Key elements for success • Building a research team • Engaging others in your research • Be engaged in the work of others who collaborate with your research • Know some basic accounting • Learn how to navigate the system • Publish your work • Make sure your staff are well trained

  3. Personnel • Your research program’s success depend on the “buy-in” from your team: • Other investigators: • Oncologists, laboratory scientists, pathologists, radiologists, etc. • Trial nurses, clinical research associates • Pharmacists • Biostatisticians • Meet with them regularly and tell them what’s happening!

  4. Resources - institutional • Grants and contracts services • Research financial services • Technology development and commercialization • Institutional review board/research ethics board/ethics committee (IRB/REB/EC) • Protocol review committee

  5. Step-by-step guide to activating a clinical trial - 1 • Concept --- protocol development • Pharmaceutical-sponsored • Investigator-initiated research (IIR) • Academic agency-sponsored (e.g. NCIC, NCI, RTOG, etc) • Once confidential non-disclosure is established, review the protocol in detail, and asks key individuals in your research team for input • Protocol review committee (if any)

  6. Step-by-step guide to activating a clinical trial - 2 • Key questions you need to ask before deciding to take part: • Do you have enough patients to put on the trial? • Do you have any competing trials? • Do you have the personnel to run the trial? • Do you have the resources and infrastructure to run the trial (e.g. electronic data capture; IV pumps; treatment space, etc)?

  7. Step-by-step guide to activating a clinical trial - 3 • Once you decide to participate in a study, the following processes should be activated: • Grants and contracts office – existent templates would expedite contract review • Budget – you (or someone familiar with the costs of procedures and tests in your institution) need to review this carefully • IRB/REB/EC submission

  8. Example of budget items – don’t forget the overhead (indirect costs)!

  9. Step-by-step guide to activating a clinical trial - 3 • Health Canada submission for a Clinical Trials Application (CTA): • Pharmaceutical-sponsored – done by company or by a Clinical/Contract Research Organization (CRO) • Investigator-initiated research (IIR) – you may have to do this yourself! • Academic agency-sponsored (e.g. NCIC, NCI, RTOG, etc) – done by the sponsor ususally the academic agency itself. Typically done prior to IRB submission

  10. Step-by-step guide to activating a clinical trial - 4 • Protocol submission: • IRB/REB/EC • Format consent forms to meet your institutional format and IRB preferred language • Other institutional committees that need to approve of protocol before activation

  11. Step-by-step guide to activating a clinical trial - 5 • Collecting documents prior to trial activation: • PI and investigator CVs, GCP certificates • Lab licenses/certificates, normal ranges • Financial disclosure agreements

  12. Regulatory binder index

  13. Step-by-step guide to activating a clinical trial - 6 • Site initiation visit (SIV) • Personnel/signature log • Drug and protocol review • Investigator responsibilties • Patient enrollment procedures • Serious adverse event reporting • Handling and shipment of biological samples • Drug shipment, storage, dispense • CRF completion

  14. Future state value stream map for the protocol development process McJoynt, T. A. et al. J Clin Oncol; 27:3855-3860 2009

More Related